Navigation Links
Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
Date:11/21/2007

LAVAL, QC, Nov. 21 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has received a written response from the U.S. Food and Drug Administration (FDA) regarding its appeal of the Agency's Approvable Letter for its once-daily tramadol formulation through the Formal Dispute Resolution process. In the response, the Acting Director of the Office of Drug Evaluation II, Center for Drug Evaluation and Research has not overturned the decision in the Agency's Approvable Letter of May 2007.

Labopharm plans to appeal the matter to the next supervisory level at the FDA in the coming weeks.

Labopharm initiated the Formal Dispute Resolution process in October of this year after receiving an Approvable Letter from the FDA for its once-daily formulation of tramadol in May.

About the FDA's Formal Dispute Resolution Process

FDA regulations provide a mechanism for those seeking regulatory approval of a drug product through a New Drug Application (NDA) to obtain formal review of any Agency decision through a Formal Dispute Resolution process by raising the matter with the supervisor of the employee who made the decision. If the issue is not resolved at the primary supervisory level, the applicant may request that the matter be reviewed at the next higher supervisory level. This process may continue through the Agency's chain of command, through the Centers to the Commissioner of Food and Drugs. The Formal Dispute Resolution process exists to encourage open, prompt discussion of scientific (including medical) disputes and procedural (including administrative) disputes that arise during the drug development, new drug review, generic drug review, and post-marketing oversight processes.

About Labopharm Inc.

Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily fo
'/>"/>

SOURCE Labopharm Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
9. DaVita Receives Civil Complaint
10. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008).../ -- The University of Texas M. D. Anderson Canc...effort to eradicate breast cancer in Panama throug...Research of the Americas today at an event with La... Vivian Fernandez de Torrijos, the First Lady of P...itiative are the U.S. Department of State and Susa...
(Date:11/21/2008)...eneral membership of the Medical,Advertising Hall...their Annual,Awards Dinner to be held February 10...e Achievement Award will also be given. , T...l of Fame are: , Ronald Pantello, who began his...udler & Hennessey. In 1980 he left Sudler &...
(Date:11/21/2008)...its cause remains a mysteryswept into Athens. The ... soldiers and refugees of the war then raging betw...ses, social order broke down. Over the next three ...a third of its population. It lost the war too. Th... of the Golden Age of Greece. , The Plague of A...
(Date:11/21/2008)...ope Research(TM), a revolutionary,biometric media...Measurement,announced today the appointment of t... research and development, business strategy and m...ents, who deliver a combined 60 years of experienc...er and Vice President of,Strategy; Dr. Ravi Kothu...
Breaking Medicine News(10 mins):Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2
...vity disorder (ADHD), is a common neurobehavioral ... are prescribed// stimulant medications. A new stu... lifeless and/or alienated from one’s peers, child...cations. ADHD is affecting 4.4 million children in...
...llowed the discovery of neural stem cells and thei...ries of the brain and spinal cord//, recent resear...ion of cells that appear to be the source of cells...ly, if these mother cells can be destroyed, the tu...
...s aged 15 years and above is overweight or obese, ...sion and diabetes//. The study has a bearing on S...ies among the people's food habits and lifestyle i... Data from this study confirms that excess weight...
...in a middle school in south China's Guangxi Zhuang...al, an official said Friday//. All the students ha...le 21 have been diagnosed as suffering from sympto...spected of coming down with the disease, said Gong...
Other Medicine News:Health News:Genes That Allow Brain Cancer-Causing Stem Cells to Resist Treatment Identified 2Health News:Genes That Allow Brain Cancer-Causing Stem Cells to Resist Treatment Identified 3
(Date:11/20/2008)..., Nov. 20 The following...er Equity: , , WHAT: World AIDS Day Audio...y, November 25, 2008 , 11:00 a.m. EST , Call...uraged: https://cc.readytalk.com/r/1xe41i2yre8rs ...ng the number of people newly put on treatment wor...
(Date:11/20/2008)... Calif., Nov. 20 Milk. It does a b...originally thought. After years of,research, scie...es found in,cow,s milk that stimulate the body,s ...ew the Multimedia News Release, go to:, http://www... While developing new cancer therapies, the chie...
(Date:11/20/2008)...v. 20 PAREXEL Internatio...l biopharmaceutical services provider, today annou... provide regulatory consulting and clinical resear...ice, PAREXEL now has locations throughout five imp... which also include Argentina, Brazil, Chile, and ...
(Date:11/19/2008)...cientists report basic findings on critical enzyme... better treat an array of disorders , , MEM...cientists at St. Jude Children,s Research Hospital...f the body,s enzyme workhorses called calpains. ,...alpains function in many cellular processes, inclu...
Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Chinas Anti Aging Revolution 7709 1Chinas Anti Aging Revolution 7709 2Chinas Anti Aging Revolution 7709 3Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology 28ASH 29 Annual Meeting 7707 1Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology 28ASH 29 Annual Meeting 7707 2Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology 28ASH 29 Annual Meeting 7707 3Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology 28ASH 29 Annual Meeting 7707 4Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology 28ASH 29 Annual Meeting 7707 5Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology 28ASH 29 Annual Meeting 7707 6Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology 28ASH 29 Annual Meeting 7707 7Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology 28ASH 29 Annual Meeting 7707 8Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology 28ASH 29 Annual Meeting 7707 9Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology 28ASH 29 Annual Meeting 7707 10Clarient CEO Andrews to Participate in Panel Discussion at the RBC Capital Markets 2007 Healthcare Conference 7705 1Clarient CEO Andrews to Participate in Panel Discussion at the RBC Capital Markets 2007 Healthcare Conference 7705 2Memory Pharmaceuticals Receives Nasdaq Notification Related to Minimum Bid Price 7703 1Memory Pharmaceuticals Receives Nasdaq Notification Related to Minimum Bid Price 7703 2Memory Pharmaceuticals Receives Nasdaq Notification Related to Minimum Bid Price 7703 3
...wswire-FirstCall/ --,Genaera Corporation today ann...ine (MSI-1436), its novel anti-obesity compound,d... Scientific,Sessions, June 22 to 25 in Chicago. , ...is a Multiple,Pathway Inhibitor that Causes Differ...s Plasma Insulin and Leptin Levels." , The poster ...
...ence , HIGH WYCOMBE, UK 18th June 2007-Previously ...u vaccine has the potential,to protect against all...al, was presented today by PepTcell, at the 2007 O...onference, in Toronto,Canada. , The pre-clinical ...ournal of Immunology, showed how mice vaccinated w...
Other Medicine Technology:Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 2Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 3Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 4New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 5
Straight shafts and serrated handle with polished finish. Teeth: Fine 1 x 2 teeth. Most popular size or model.
Straight shafts with fine Pierse type tips. Flat smooth handle with dull finish.
Serrated handle with polished finish. Non-magnetic. Straight tips: Delicate 11 mm. Most popular size or model.
Serrated handle with polished finish. Straight tips: Delicate 11 mm. Most popular size or model.
Medicine Products: